Use of activated factor VII in severe acute hemorrhage;Utilización del factor VII activado en hemorragias agudas graves

Anales de Pediatria

Volumn 62, Issue 5, 2005, Pages 467-470

  Milano Manso, G ^a,b   Rodriguez Amuedo F ^a   Aragones Manzanero R ^a   Martinez Ferriz Ma C ^a   Oliva Munoz C ^a   Calvo Macias, C ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b NONE   (Spain)

Author keywords

Blood coagulation disorders; Cardiovascular surgical procedures; Children; Factor VIIa; Hemorrhage

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; FRESH FROZEN PLASMA; VITAMIN K GROUP;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD COMPONENT; BLOOD COMPONENT THERAPY; CARDIOVASCULAR SURGERY; CASE REPORT; CHILD; DRUG RESPONSE; DRUG TOLERANCE; ERYTHROCYTE CONCENTRATE; FEMALE; HUMAN; INTENSIVE CARE; MALE; MENINGOCOCCEMIA; MYELOMONOCYTIC LEUKEMIA; POSTOPERATIVE HEMORRHAGE; SEPSIS; SPLENECTOMY; STOMACH HEMORRHAGE; THROMBOCYTE TRANSFUSION;

EID: 20444460169     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13074621     Document Type: Article

References (19)

1. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Prospective, randomised trial of 2 doses of rFVIIa (Novoseven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost. 1998;80:773-8.
2. Key NS, Aledort LM, Beardsley D, Cooper HA, Davignon G, Ewenstein BM, et al. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost. 1998;80: 912-8.
3. Mathew P, Winter SS, Frost JD, Hanrahan J, Schwartz M, Jones JE, et al. Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseases. J Pediatr Hematol Oncol. 2003;25:499-502.
4. Egan JR, Lammi A, Schell DN, Gillis J, Nunn GR. Recombinant activated factor VII in paediatric cardiac surgery. Intensive Care Med. 2004;30:682-5.
5. Martinowta U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingerslev J, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma. 2001;51: 431-9.
6. Hedner U, Ingerslev J. Clinical use of recombinat FVIIa (rVIIa). Transfus Sci. 1998;19:163-76.
7. Rao LV, Rapaport SI. Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of coagulation. Proc Natl Acad Sci USA. 1988;85:6687-91.
8. Rapaport SI, Rao LV. The tissue factor pathway: how it has become a "prima ballerina". Thromb Haemost. 1995;74:7-17.
9. Hoffman M, Monroe DM III, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets thoughs on the machanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis. 1998;9 Supl: S61-S5.
10. Blomback B, Carlsson K, Fatah K, Hessel B, Procyk R. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb Res. 1994;75:521-38.
11. Lusher J, Ingerslev J, Roberts H, Hedner U. Clinical experience with recombinant factor VIIa. Blood Coagul Fibrinolysis. 1998;9:119-28.
12. Arkin S, Cooper HA, Hutter JJ, Miller S, Schmidt ML, Seibel NL, et al. Activated recombinant human coagulation factor VII therapy for intracraneal hemorrhage in patients with hemophilia A or B with inhibitors: results of the Novoseven emergency use program. Haemostasis. 1998;28:93-8.
13. Roberts HR. Clinical experience with activated factor VII: focus on safety aspects. Blood Coagul Fibrinolysis. 1998;9 Supl I: S115-8.
14. Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis, 1998;9 Supl:S147-52.
15. Poon MC, d'Orion R, Hann I, Negrier C. De Lumley L, Thomas A, et al. Use of recombinat factor VIIa (NovoSeven) in patients with Glanzmann Thrombasthenia. Semin Hematol. 2001; 38:21-5.
16. Bernstein DE, Jeffers L, Erhardsen E, Reddy KR, Glazer S, Squiban P, et al. Recombinat factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology. 1997;113:1930-7.
17. Tobias JD, Berkenbosch JW, Russo P. Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. Pediatr Crit Care Med. 2003;4:49-51.
18. Greisen G, Andreasen RB. Recombinant factor VIIa in treterm neonates with prolonged prothrombin time. Blood Coagul Fibrinolysis. 2003;14:117-20.
19. Veldman A, Fischer D, Voigt B, Beyer PA, Schlösser R, Allendorf A, et al. Life-threatening hemorrhage in neonates: Management with recombinant activated factor VII. Intensive Care Med. 2002;28:1635-7.